Hans Hammers

Hans Hammers is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of the Division of Hematology and Oncology, holding the inaugural Eugene P. Frenkel, M.D. Scholar in Clinical Medicine position.

His educational background includes:

• Medical and doctoral degrees from the Medical University of Luebeck, Germany
• Internal medicine residency at Johns Hopkins Bayview Medical Center
• Fellowship in medical oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University

Dr. Hammers is a nationally recognized leader in kidney cancer research with pioneering contributions to immunotherapy, particularly immune checkpoint inhibitors. His work focuses on developing novel immunotherapies for kidney cancer, leveraging his expertise as a board-certified medical oncologist. This research has established foundational approaches now widely adopted in clinical oncology.

His scientific awards include:

• Eugene P. Frenkel, M.D. Scholar in Clinical Medicine

As Co-Leader of Clinical Research and Immunotherapy for the Kidney Cancer Research Program, Dr. Hammers directs strategic initiatives while serving as principal investigator on multiple industry-sponsored and investigator-initiated clinical trials. He maintains active membership in major professional organizations including the American Society of Clinical Oncology, American Association for Cancer Research, and Society for Immunotherapy of Cancer.